Block A, Building 2, No.158 Xinjunhuan Road, Pujiang Town,Minhang District, Shanghai,China
Genomic Profiling System(GPS)
Application: Solid-tumor patients seeking targeted therapies
Product Advantages:
Covering all exon regions of 733 genes and intron regions of 43 fusion genes
Containing 102 genetically susceptible genes, it can precisely and comprehensively assess the risk of genetic susceptibility
The TMB algorithm, which is certified by Jama Oncology, has been doubly verified by technology and clinic. Immunological efficacy can be accurately predicted by the Chinese people TMB big database.
500 MSI sites, which can accurately predict the immunological efficacy, has been doubly verified by technology and clinic.
Covering 215 DDR pathway-related genes comprehensively, large genomic rearrangements can be detected by exclusive patented technology. Patients groups benefited by PARP inhibitors-targeted therapy can be expanded, assisting accurate genetic screening
Sincerely Pharmaceutical Tech
Regards,
Client Success Team (CRM),
Please fill the all required fields....!!
Sincerely Packaging Labelling
